Table 3.

Outcomes of randomized controlled trials comparing total hepatic inflow occlusion with hemihepatic vascular occlusion

Author (yr)	Operative time (min)	Ischemic duration (min)	Blood loss (mL)	Transfusion requirements	Complications total (n)	In-hospital stay (d)	In-hospital death (n)
	THO/HHO	THO/HHO	THO/HHO	THO/HHO	THO/HHO	THO/HHO	THO/HHO
Figueras et al (2005)	207 ± 48/219 ± 45	41 ± 14/47 ± 18	671 ± 533/735 ±397	4:39/6:41	15:39/ 12:41	9.38 ± 4.9/8.15 ± 3.8	0:39/1:41
Wu et al (2002)	409 ± 19.2/ 399 ± 15.6	96.0 ± 10.9/ 94.2 ± 9.9	1685 ± 170/ 1159 ± 221	12:28/5:30	8:28/10:30	14.8 ± 1.4/16.4 ± 1.4	0:28/0:30
Yuan et al (2010)	114.2 ± 37.2/ 133.5 ± 44.6	16.6 ± 8.7/ 14.9 ± 4.5	339.5 ± 205.1/ 354.4 ± 240.3	6:60/4:60	19:60/12:60	13.7 ± 5.2/10.2 ±4.1	1:60/0:60
Liang et al (2009)	203.98 ± 38.36/ 236.15 ± 49.2	40.17 ± 13.30/ 42.38 ± 12.79	569.8 ± 285.56/ 649.35 ± 279.05	14:40/15:40	8:40/9:40	9.85 ± 3.55/10.12 ± 2.41	0:40/0:40
Total	--	--	--	36:167/30:171	50:167/43:171	--	1:167/1:171

THO: Total hepatic inflow occlusion; HHO: Hemihepatic vascular occlusion.